Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

NEUMORA THERAPEUTICS, INC. (NMRA) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

NEUMORA THERAPEUTICS, INC. (NMRA), most recent 12 months reported: net loss $212.75M. Latest balance sheet on file: liquid cash $116.83M, total debt $52.91M, net cash $63.92M. From SEC filings. Others in Biological Products, (No Diagnostic Substances): LIMINATUS PHARMA, INC. · LeonaBio, Inc. · Lexeo Therapeutics, Inc. · MAZE THERAPEUTICS, INC. · OUTLOOK THERAPEUTICS, INC. · PALISADE BIO, INC. · PASSAGE BIO, INC. · Vaxcyte, Inc.

Stock screener

Watchlist